• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Elevated inflammatory biomarkers linked with increased risk of COPD exacerbations

bys25qthea
June 12, 2013
in Chronic Disease, Infectious Disease, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Elevated levels of CRP, fibrinogen, and leukocyte count are associated with an increased risk of COPD exacerbations over one year.

2. There was a stepwise increase in the risk of frequent exacerbations over the 1, 3, and 5 year follow-up period based upon the number of biomarkers present.

Evidence Rating Level: 2 (Good)

Study Rundown: This study showed that the combination of elevated levels of C-reactive protein (CRP), fibrinogen, and leukocyte count was associated with a stepwise increased risk of chronic obstructive pulmonary disease (COPD) exacerbations, even in patients with mild disease. The present study is the first study to demonstrate the association between all 3 different inflammatory biomarkers and the risk of frequent COPD exacerbations.

There are several limitations to the study which must be addressed with further research before these biomarkers are used in everyday clinical practice. First, the study includes more mild to moderate COPD cases relative to severe cases, and further validation may be warranted for all subsets of COPD patients. Furthermore, it is possible that there may be omitted cases of mild COPD that were misdiagnosed as acute bronchitis, which could affect the study’s interpretation of inflammatory biomarkers. Nonetheless, this prospective cohort study was well executed and may herald a greater use of inflammatory markers in the management of COPD patients if further studies may validate the findings of this study.

Click to read the study, published today in JAMA

RELATED REPORTS

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis

Black patients with pulmonary fibrosis may have worse outcomes compared to other populations

Click to read the editorial, published today in JAMA

Relevant Reading: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary

In-Depth [prospective, cohort study]: This study selected 8,020 individuals from 2 general population studies in Copenhagen, stratified according to age and Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades 1-4 and A-D. Plasma levels of high sensitivity CRP, fibrinogen, and whole blood leukocyte count were measured, along with exacerbations. Over the first year of follow-up, the odds ratio for frequent exacerbations were 1.5, 2.6, and 6.4 for the 3 respective groups compared to patients without elevated biomarkers (p= 3×10-11). Among 3 groups in comparison to patients without elevated biomarkers, hazard ratios for having at least 1 exacerbation were 1.2, 1.3, and 1.8 (p=2×10-7), respectively. A similar stepwise increase in frequency was seen in the absolute 1 year, 3 year, 5 year risk of frequent exacerbations from none to 3 elevated biomarkers across all GOLD grades A-D, 1-4, and those with history of frequent exacerbations.

By Elizabeth Park and Rif Rahman

More from this author:Trigger exposure in migraine patients results in migraine with aura only in a small subset of patients, Choosing a prenatal diagnostic test: Microarray analysis shown equal to karyotyping,STEMO unit delivery of tpa reduces call to needle time in acute stroke patients,High-dose multivitamin supplements do not decrease disease progression or death in HIV patients receiving HAART ,Pediatric patients not receiving quality palliative care despite agreement between parents and caregivers on valued elements of care ,Combined BRAF and MEK inhibition in metastatic melanoma significantly improves progression free survival

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: biomarkerscopdhealthinflammationpulmonologysmoking
Previous Post

The EVAR I trial: Endovascular vs. open abdominal aortic aneurysm repair [Classics Series]

Next Post

A marker of aggressive liver cancer and potential therapeutic target identified

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

March 21, 2023
Quick Take: Discovery and validation of a prognostic proteomic signature for tuberculosis progression
Chronic Disease

Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis

March 17, 2023
Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT
Chronic Disease

Black patients with pulmonary fibrosis may have worse outcomes compared to other populations

March 16, 2023
Hidradenitis suppurativa associated with increased risk of subclinical atherosclerosis
Chronic Disease

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

March 16, 2023
Next Post
A marker of aggressive liver cancer and potential therapeutic target identified

A marker of aggressive liver cancer and potential therapeutic target identified

On-demand inhalation treatment for bronchiolitis is superior to fixed schedule treatment

On-demand inhalation treatment for bronchiolitis is superior to fixed schedule treatment

Reducing surgical complications may increase costs

Postoperative complications linked with unplanned hospital readmissions

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Active surveillance strategies to improve rates of inferior vena cava filter retrieval
  • Intranasal vaccine against Bordetella pertussis invokes seronegative IgA response
  • Hydrochlorothiazide does not impact risk of kidney-stone recurrence
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options